US Clinicians Missing the Mark for Albuminuria Testing, Preventing Optimal CKD Care
Using NHANES data, along with deidentified data from the Optum database, investigators estimate the prevalence of albuminuria testing among people with hypertension or diabetes as well as how the presence or lack of testing might influence prescription of CKD therapies.
Source: hcplive.com